Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK - the study of the way a
drug enters and leaves the blood and tissues over time) and relative bioavailability (the
extent to which a drug or other substance becomes available to the body) of JNJ-56021927,
when administered as 3 tablet formulations (test) compared with JNJ-54781532 softgel capsule
formulation (reference) in healthy male participants under fasted conditions at a single dose
of 240 milligram (mg).